Quote For OSI Pharmaceuticals, Inc. OSIP.O
sector: Healthcare ·
industry: Biotechnology ·
As of
27 Nov 2009
33.11USD
$33.11
27 Nov 2009
+0.33%
$33.00
$32.47
179,111
$33.23
$32.30
$43.00
$27.01
0.71
510,010
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Ingram, Robert |
Chairman of the Board |
-- |
| Goddard, Colin |
Chief Executive Officer, Director |
2,794,810 |
| Legault, Pierre |
Chief Financial Officer, Executive Vice President, Treasurer |
149,766 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$1,921.95 |
| Shares Outstanding (Mil.) |
58.05 |
| Float (Mil.) |
0.81 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
0.00 |
| |
| Financial Strength |
| Quick Ratio |
10.97 |
| Current Ratio |
10.94 |
| LT Debt/Equity |
55.83 |
| Total Debt/Equity |
55.83 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
5.20 |
| Price/Sales(TTM) |
4.77 |
| Price/Book(TTM) |
2.82 |
| Price/Cash Flow(TTM) |
4.52 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$7.18 |
| Sales(TTM) |
$6.49 |
| Book Value(MRQ) |
$11.72 |
| Cash Flow(TTM) |
$6.85 |
| Cash(MRQ) |
$9.31 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
93.22 |
| Return on Assets(TTM) |
43.66 |
| Return on Investment(TTM) |
46.78 |
| |
|
| Margins |
| Gross Margin(TTM) % |
97.36 |
| Operating Margin(TTM) % |
32.46 |
| Profit Margin(TTM) % |
102.84 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives